Neoxinal (Chlorhexidine Gluconate)

Chlorhexidine gluconate acts by binding to the phospholipid membranes of microorganisms, disrupting their integrity. This leads to leakage of intracellular components and rapid cell death, providing broad‑spectrum antimicrobial activity against bacteria, some fungi and viruses on the skin surface.

The appropriate amount of Neoxinal is determined by the prescribing health‑care professional based on the specific clinical situation. Users should follow the instructions provided by the clinician or the product label for the correct application quantity.

Safety data for chlorhexidine gluconate in pregnancy and lactation are limited. Health‑care providers should evaluate the risk‑benefit profile for each individual. Generally, topical use on intact skin is considered low risk, but consultation with a medical professional is advised.

To request Neoxinal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with alcohol‑based antiseptics, chlorhexidine (Neoxinal) offers longer residual activity on the skin and is less irritating for many patients. Unlike povidone‑iodine, it does not stain the skin and has a broader antimicrobial spectrum, making it a preferred choice for pre‑operative skin preparation in many settings.

Neoxinal should be stored at ambient temperature, away from direct sunlight and moisture. Keep the container tightly closed when not in use and protect it from extreme temperatures to maintain product stability.

Neoxinal is applied topically to clean, intact skin. The solution is typically spread evenly over the target area using a sterile swab or gauze, allowed to dry, and then covered or left uncovered according to the clinical protocol.

The most serious risks include severe allergic reactions such as anaphylaxis, ototoxicity if inadvertently introduced into the ear canal, and rare cases of chemical burns from excessive or prolonged exposure. Immediate medical attention is required if any of these symptoms occur.

Neoxinal should not be used on mucous membranes, the eyes, or on large open wounds without medical supervision. Individuals with known hypersensitivity to chlorhexidine or related compounds should avoid its use, and it is contraindicated in patients with ear conditions when applied near the ear canal.